C07C 251/32
Oximes
C07C251/32 (Oximes) appears on 1,069 US grants and 672 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,069
- Published applications
- 672
- Assignees
- 457
- Inventors
- 2,663
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 1 | 0 |
| 1978 | 7 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 6 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 8 | 0 |
| 1990 | 9 | 0 |
| 1991 | 22 | 0 |
| 1992 | 25 | 0 |
| 1993 | 31 | 0 |
| 1994 | 30 | 0 |
| 1995 | 33 | 0 |
| 1996 | 61 | 0 |
| 1997 | 65 | 0 |
| 1998 | 47 | 0 |
| 1999 | 57 | 0 |
| 2000 | 50 | 0 |
| 2001 | 63 | 11 |
| 2002 | 50 | 31 |
| 2003 | 35 | 31 |
| 2004 | 22 | 45 |
| 2005 | 17 | 22 |
| 2006 | 17 | 30 |
| 2007 | 22 | 29 |
| 2008 | 25 | 37 |
| 2009 | 17 | 31 |
| 2010 | 21 | 27 |
| 2011 | 23 | 40 |
| 2012 | 20 | 23 |
| 2013 | 21 | 30 |
| 2014 | 27 | 27 |
| 2015 | 33 | 39 |
| 2016 | 28 | 32 |
| 2017 | 25 | 28 |
| 2018 | 20 | 25 |
| 2019 | 20 | 16 |
| 2020 | 22 | 20 |
| 2021 | 12 | 11 |
| 2022 | 11 | 23 |
| 2023 | 13 | 29 |
| 2024 | 7 | 17 |
| 2025 | 13 | 9 |
| 2026 | 9 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Plant disease control composition and plant disease control method25 Aug 2026US 12,714,103 B2Sumitomo Chemical Company, Limited
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Substrate treating method16 Jun 2026US 12,660,547 B2SCREEN Holdings Co., Ltd.
- Styryl carboxylate derivatives26 May 2026US 12,637,409 B2Renovel Innovations, Inc.
- Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents7 Apr 2026US 12,595,226 B2ModernaTX, Inc.
- Organic compound (oxime) to combat chemical warfare agents1 Oct 2026US 2026/0297032 A1Prepaire Labs Limited
- Aldoxime antibiotics and related methods24 Sep 2026US 2026/0283985 A1
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- New process for the manufacture of mdm2-p53 antagonists23 Jul 2026US 2026/0209169 A1Boehringer Ingelheim International GmbH
- Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors xv18 Jun 2026US 2026/0165323 A1BASF SE
Most cited
By later US patents
- Oxime ester photoiniators having a combined structure283US 7,189,489 B2Ciba Specialty Chemicals Corporation · 2007
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives142US 4,826,969 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1989
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015